Orbimed Advisors - RXSIGHT INC ownership

RXSIGHT INC's ticker is and the CUSIP is 78349D107. A total of 54 filers reported holding RXSIGHT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of RXSIGHT INC
ValueSharesWeighting
Q1 2023$20,063,254
+31.6%
1,202,8330.0%0.39%
+34.9%
Q4 2022$15,239,894
+5.6%
1,202,8330.0%0.29%
+9.0%
Q3 2022$14,434,000
-25.9%
1,202,833
-13.1%
0.27%
-24.1%
Q2 2022$19,480,000
+13.7%
1,383,5000.0%0.35%
+27.0%
Q1 2022$17,128,000
+10.0%
1,383,5000.0%0.28%
+39.0%
Q4 2021$15,564,000
-1.7%
1,383,500
+10.7%
0.20%
+14.9%
Q3 2021$15,838,0001,250,0000.17%
Other shareholders
RXSIGHT INC shareholders Q3 2022
NameSharesValueWeighting ↓
Divisadero Street Capital Management, LP 680,000$18,965,2005.98%
NEXT CENTURY GROWTH INVESTORS LLC 747,827$20,856,8952.27%
Parkman Healthcare Partners LLC 381,331$10,635,3221.95%
Atika Capital Management LLC 509,352$14,205,8281.86%
RA Capital Management 3,052,796$85,142,4801.68%
EAM Investors, LLC 163,168$4,550,7560.88%
No Street GP LP 250,000$6,972,5000.83%
ADVISORY RESEARCH INC 156,189$4,356,1120.60%
Lisanti Capital Growth, LLC 123,205$3,436,1870.54%
Alpha DNA Investment Management LLC 20,879$582,3150.24%
View complete list of RXSIGHT INC shareholders